Archive > Volume 29 Issue 10 > 2022,29(10):950-955. DOI:10.3872/j.issn.1007-385X.2022.10.012 Prev Next

Review

Research progress on GPC3-targeted immunotherapy for hepatocellular carcinoma

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.